• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极低出生体重伴先天性胰腺发育不良的新生儿糖尿病采用未稀释胰岛素充盈胰岛素输注泵治疗:16 个月随访结果。

Very low birth weight newborn with diabetes mellitus due to pancreas agenesis managed with insulin pump reservoir filled with undiluted insulin: 16-month follow-up.

机构信息

Regional Center for Pediatric Diabetes, Department of Pediatrics, University of the Study of Campania, via Sant'Andrea delle Dame,4, Naples, 80138, Italy.

Regional Center for Pediatric Diabetes, Department of Pediatrics, University of the Study of Campania, via Sant'Andrea delle Dame,4, Naples, 80138, Italy.

出版信息

Diabetes Metab Syndr. 2022 Jul;16(7):102561. doi: 10.1016/j.dsx.2022.102561. Epub 2022 Jun 30.

DOI:10.1016/j.dsx.2022.102561
PMID:35809554
Abstract

BACKGROUND

When very low doses of insulin are used insulin dilution, a procedure prone to errors, is recommended.

CASE PRESENTATION

We managed a neonate with pancreas agenesis with insulin pump therapy from the first days of life to 16 months of age without insulin dilution. Predictive low glucose suspend mode first and then closed loop control were used. No episodes of severe hypoglycemia were observed.

CONCLUSIONS

Though limited to a single patient with pancreas agenesis we believe that the use of pump should be warranted in patients with permanent neonatal diabetes mellitus and intestinal malabsorption, even with undiluted insulin.

摘要

背景

当使用极低剂量胰岛素时,建议进行胰岛素稀释,这是一种容易出错的操作。

病例介绍

我们对一名患有胰腺发育不全的新生儿从出生第一天开始使用胰岛素泵治疗,直到 16 个月大,没有进行胰岛素稀释。我们使用了预测性低血糖暂停模式,然后是闭环控制。没有观察到严重低血糖发作的情况。

结论

虽然仅限于一名胰腺发育不全的患者,但我们认为即使胰岛素没有稀释,对于永久性新生儿糖尿病和肠道吸收不良的患者,也应该使用胰岛素泵进行治疗。

相似文献

1
Very low birth weight newborn with diabetes mellitus due to pancreas agenesis managed with insulin pump reservoir filled with undiluted insulin: 16-month follow-up.极低出生体重伴先天性胰腺发育不良的新生儿糖尿病采用未稀释胰岛素充盈胰岛素输注泵治疗:16 个月随访结果。
Diabetes Metab Syndr. 2022 Jul;16(7):102561. doi: 10.1016/j.dsx.2022.102561. Epub 2022 Jun 30.
2
Sensor Augmented Pump Therapy is Safe and Effective in Very Low Birth Weight Newborns Affected by Neonatal Diabetes Mellitus, With Poor Subcutaneous Tissue: Replacement of the Insulin Pump Infusion Set on the Arm, a Video Case Report.传感器增强泵疗法在皮下组织不佳的极低出生体重新生儿糖尿病患者中安全有效:手臂胰岛素泵输注装置更换,视频病例报告
J Diabetes Sci Technol. 2022 Jan;16(1):254-255. doi: 10.1177/19322968211043112. Epub 2021 Sep 2.
3
Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.传感器增强型胰岛素泵治疗伴低血糖暂停功能在 1 型糖尿病患者中的长期疗效和安全性。
Diabetes Technol Ther. 2017 Feb;19(2):109-114. doi: 10.1089/dia.2016.0332. Epub 2016 Dec 21.
4
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.双激素人工胰腺、单激素人工胰腺与常规胰岛素泵治疗对 1 型糖尿病患者血糖控制的比较:一项开放标签随机对照交叉试验。
Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26. doi: 10.1016/S2213-8587(14)70226-8. Epub 2014 Nov 27.
5
Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study.从预混胰岛素泵技术切换到混合闭环系统可改善血糖控制并降低血糖变异性:一项回顾性观察性病例对照研究。
Diabetes Technol Ther. 2020 Apr;22(4):321-325. doi: 10.1089/dia.2019.0302. Epub 2020 Feb 11.
6
Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.可穿戴人工胰腺或带闭环系统的床边人工胰腺在血糖控制方面的当前研究主题。
J Artif Organs. 2016 Sep;19(3):209-18. doi: 10.1007/s10047-016-0904-y. Epub 2016 May 3.
7
Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.商业化混合闭环系统对儿童和成人血糖控制、血糖变异性和患者相关结局影响的前瞻性分析:重点关注优于预测性低血糖暂停技术。
Diabetes Technol Ther. 2020 Dec;22(12):912-919. doi: 10.1089/dia.2019.0400. Epub 2020 Aug 28.
8
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.应用仿生胰腺与常规胰岛素泵治疗对青春期前 1 型糖尿病患儿的血糖昼夜控制:一项随机交叉试验。
Lancet Diabetes Endocrinol. 2016 Mar;4(3):233-243. doi: 10.1016/S2213-8587(15)00489-1. Epub 2016 Feb 3.
9
Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes.胰岛素输注和儿童青少年 1 型糖尿病患者的夜间血糖控制。
Expert Opin Drug Deliv. 2017 Dec;14(12):1367-1377. doi: 10.1080/17425247.2017.1360866. Epub 2017 Aug 18.
10
Successful Use of Dilute Insulin in an Insulin Pump in Hybrid Closed Loop in an Infant.稀释胰岛素在婴儿混合闭环胰岛素泵中的成功应用。
Diabetes Technol Ther. 2022 Feb;24(2):148-151. doi: 10.1089/dia.2021.0360. Epub 2021 Oct 13.

引用本文的文献

1
Neonatal diabetes-associated missense PDX1 variant disrupts chromatin association and protein-protein interaction.新生儿糖尿病相关的错义PDX1变体破坏染色质结合和蛋白质-蛋白质相互作用。
JCI Insight. 2025 Jun 9;10(11). doi: 10.1172/jci.insight.189343.
2
Insulin Delivery Technology for Treatment of Infants with Neonatal Diabetes Mellitus: A Systematic Review.用于治疗新生儿糖尿病患儿的胰岛素给药技术:一项系统评价
Diabetes Ther. 2024 Nov;15(11):2293-2308. doi: 10.1007/s13300-024-01653-z. Epub 2024 Sep 18.
3
Pancreas agenesis and fetal growth: a semi-quantitative analysis.
胰腺发育不全与胎儿生长:一项半定量分析
Endocr Connect. 2024 Jan 1;13(3). doi: 10.1530/EC-23-0500.